North America represents a major market for smart biopsy devices due to the rising prevalence of cancer, increasing utilization of image-guided diagnostic procedures, and the presence of leading medical technology companies. The region's focus on improving diagnostic accuracy and expanding access to advanced healthcare technologies is contributing to sustained market growth. The Smart Biopsy...